Phthalazinone inhibitors of inosine-5'-monophosphate dehydrogenase from Cryptosporidium parvum

Bioorg Med Chem Lett. 2013 Feb 15;23(4):1004-7. doi: 10.1016/j.bmcl.2012.12.037. Epub 2012 Dec 27.

Abstract

Cryptosporidium parvum (Cp) is a potential biowarfare agent and major cause of diarrhea and malnutrition. This protozoan parasite relies on inosine 5'-monophosphate dehydrogenase (IMPDH) for the production of guanine nucleotides. A CpIMPDH-selective N-aryl-3,4-dihydro-3-methyl-4-oxo-1-phthalazineacetamide inhibitor was previously identified in a high throughput screening campaign. Herein we report a structure-activity relationship study for the phthalazinone-based series that resulted in the discovery of benzofuranamide analogs that exhibit low nanomolar inhibition of CpIMPDH. In addition, the antiparasitic activity of select analogs in a Toxoplasma gondii model of C. parvum infection is also presented.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiparasitic Agents / pharmacology*
  • Cryptosporidiosis / drug therapy
  • Cryptosporidium parvum / drug effects*
  • Cryptosporidium parvum / enzymology*
  • Enzyme Inhibitors / chemistry
  • Enzyme Inhibitors / pharmacology*
  • Humans
  • IMP Dehydrogenase / antagonists & inhibitors*
  • IMP Dehydrogenase / metabolism
  • Phthalazines / chemistry
  • Phthalazines / pharmacology*
  • Structure-Activity Relationship

Substances

  • Antiparasitic Agents
  • Enzyme Inhibitors
  • Phthalazines
  • IMP Dehydrogenase